-
1
-
-
0032826035
-
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
-
Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens J, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert J-M, Smits J, Shapiro SD, Baes M, Borgers M, Collen D, Daemen M, Carmeliet P. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med. 1999;5:1135-1142.
-
(1999)
Nat Med
, vol.5
, pp. 1135-1142
-
-
Heymans, S.1
Luttun, A.2
Nuyens, D.3
Theilmeier, G.4
Creemers, E.5
Moons, L.6
Dyspersin, G.D.7
Cleutjens, J.8
Shipley, M.9
Angellilo, A.10
Levi, M.11
Nube, O.12
Baker, A.13
Keshet, E.14
Lupu, F.15
Herbert, J.-M.16
Smits, J.17
Shapiro, S.D.18
Baes, M.19
Borgers, M.20
Collen, D.21
Daemen, M.22
Carmeliet, P.23
more..
-
2
-
-
14344281434
-
Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure
-
Peterson JT, Hallak H, Johnson L, Li H, O'Brien PM, Sliskovic DR, Bocan TMA, Coker ML, Etoh T, Spinale FG. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation. 2001;103:2303-2309.
-
(2001)
Circulation
, vol.103
, pp. 2303-2309
-
-
Peterson, J.T.1
Hallak, H.2
Johnson, L.3
Li, H.4
O'Brien, P.M.5
Sliskovic, D.R.6
Bocan, T.M.A.7
Coker, M.L.8
Etoh, T.9
Spinale, F.G.10
-
3
-
-
0037230181
-
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice
-
Creemers EE, Davis JN, Parkhurst AM, Leenders P, Dowdy KB, Hapke E, Hauet AM, Escobar PG, Cleutjens JP, Smits JF, Daemen MJ, Zile MR, Spinale FG. Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am J Physiol. 2002;284:H364-H371.
-
(2002)
Am J Physiol
, vol.284
-
-
Creemers, E.E.1
Davis, J.N.2
Parkhurst, A.M.3
Leenders, P.4
Dowdy, K.B.5
Hapke, E.6
Hauet, A.M.7
Escobar, P.G.8
Cleutjens, J.P.9
Smits, J.F.10
Daemen, M.J.11
Zile, M.R.12
Spinale, F.G.13
-
4
-
-
0033932709
-
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
-
Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest. 2000;106:55-62.
-
(2000)
J Clin Invest
, vol.106
, pp. 55-62
-
-
Ducharme, A.1
Frantz, S.2
Aikawa, M.3
Rabkin, E.4
Lindsey, M.5
Rohde, L.E.6
Schoen, F.J.7
Kelly, R.A.8
Werb, Z.9
Libby, P.10
Lee, R.T.11
-
5
-
-
0037417940
-
Myocardial infarct expansion and matrix metalloproteinase inhibition
-
Mukherjee R, Widener CE, Brinsa TA, Dowdy KB, Scott AA, Sample JA, Hendrick JW, Escobar GP, Joffs C, Lucas DG, Zile MR, Spinale FG. Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation. 2003;107:618-625.
-
(2003)
Circulation
, vol.107
, pp. 618-625
-
-
Mukherjee, R.1
Widener, C.E.2
Brinsa, T.A.3
Dowdy, K.B.4
Scott, A.A.5
Sample, J.A.6
Hendrick, J.W.7
Escobar, G.P.8
Joffs, C.9
Lucas, D.G.10
Zile, M.R.11
Spinale, F.G.12
-
6
-
-
0038796894
-
Region and species specific induction of matrix metalloproteinases occurs with post-myocardial infarction remodeling
-
Wilson EM, Moainie SL, Baskin JM, Lowry AS, Deschamps AM, Mukherjee R, Guy TS, St John-Sutton MG, Gorman JH, Edmunds LH, Gorman RC, Spinale FG. Region and species specific induction of matrix metalloproteinases occurs with post-myocardial infarction remodeling. Circulation. 2003;107:2857-2863.
-
(2003)
Circulation
, vol.107
, pp. 2857-2863
-
-
Wilson, E.M.1
Moainie, S.L.2
Baskin, J.M.3
Lowry, A.S.4
Deschamps, A.M.5
Mukherjee, R.6
Guy, T.S.7
St John-Sutton, M.G.8
Gorman, J.H.9
Edmunds, L.H.10
Gorman, R.C.11
Spinale, F.G.12
-
7
-
-
0037155784
-
Matrix metalloproteinases; regulation and dysregulation in the failing heart
-
Spinale FG. Matrix metalloproteinases; regulation and dysregulation in the failing heart. Circ Res. 2002;90:520-530.
-
(2002)
Circ Res
, vol.90
, pp. 520-530
-
-
Spinale, F.G.1
-
8
-
-
0001796893
-
The matrix metalloproteinase family
-
Parks WC, Mecham RP, eds. San Diego, Calif: Academic Press
-
Woessner FJ. The matrix metalloproteinase family. In: Parks WC, Mecham RP, eds. Matrix Metalloproteinases. San Diego, Calif: Academic Press; 1998:1-141.
-
(1998)
Matrix Metalloproteinases
, pp. 1-141
-
-
Woessner, F.J.1
-
10
-
-
0036800192
-
Metalloproteinase inhibitors: Biological actions and therapeutic opportunities
-
Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci. 2002;115(pt 19):3719-3727.
-
(2002)
J Cell Sci
, vol.115
, Issue.19 PART
, pp. 3719-3727
-
-
Baker, A.H.1
Edwards, D.R.2
Murphy, G.3
-
11
-
-
0141954175
-
Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling
-
Yarbrough WM, Mukherjee R, Escobar GP, Mingoia JT, Sample JA, Hendrick JW, Dowdy KB, McLean JE, Spinale FG. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling. Circulation. 2003;108:1753-1759.
-
(2003)
Circulation
, vol.108
, pp. 1753-1759
-
-
Yarbrough, W.M.1
Mukherjee, R.2
Escobar, G.P.3
Mingoia, J.T.4
Sample, J.A.5
Hendrick, J.W.6
Dowdy, K.B.7
McLean, J.E.8
Spinale, F.G.9
-
12
-
-
0035806907
-
Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices
-
Li YY, Feng Y, McTiernan CF, Pei W, Moravec CS, Wang P, Rosenblum W, Kormos RL, Feldman AM. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation. 2001;104;1147-1152.
-
(2001)
Circulation
, vol.104
, pp. 1147-1152
-
-
Li, Y.Y.1
Feng, Y.2
McTiernan, C.F.3
Pei, W.4
Moravec, C.S.5
Wang, P.6
Rosenblum, W.7
Kormos, R.L.8
Feldman, A.M.9
-
13
-
-
0034680366
-
A matrix metalloproteinase induction/activation system exists in the human myocardium and is upregulated in heart failure
-
Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, Goldberg AT, Zellner JL, Crumbley AJ. A matrix metalloproteinase induction/activation system exists in the human myocardium and is upregulated in heart failure. Circulation. 2000;102;1944-1949.
-
(2000)
Circulation
, vol.102
, pp. 1944-1949
-
-
Spinale, F.G.1
Coker, M.L.2
Heung, L.J.3
Bond, B.R.4
Gunasinghe, H.R.5
Etoh, T.6
Goldberg, A.T.7
Zellner, J.L.8
Crumbley, A.J.9
-
14
-
-
0037132639
-
Differential release of matrix metalloproteinases (MMP's) and tissue inhibitors of matrix metalloproteinases (TIMP's) in patients following alcohol induced myocardial infarction
-
Bradham WS, Gunasinghe H, Wendt K, Holder J, Multani M, Spencer W, Killip D, Anderson M, Meyer D, Spinale FG. Differential release of matrix metalloproteinases (MMP's) and tissue inhibitors of matrix metalloproteinases (TIMP's) in patients following alcohol induced myocardial infarction. J Am Coll Cardiol. 2002;40:2165-2173.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 2165-2173
-
-
Bradham, W.S.1
Gunasinghe, H.2
Wendt, K.3
Holder, J.4
Multani, M.5
Spencer, W.6
Killip, D.7
Anderson, M.8
Meyer, D.9
Spinale, F.G.10
-
15
-
-
0034996905
-
Cardiopulmonary bypass induces the synthesis and releases of matrix metalloproteinases
-
Joffs C, Gunasinghe HR, Multani MM, Dorman BH, Kratz JM, Crumbley AJ, Crawford FA, Spinale FG. Cardiopulmonary bypass induces the synthesis and releases of matrix metalloproteinases. Ann Thorac Surg. 2001;71:1518-1523.
-
(2001)
Ann Thorac Surg
, vol.71
, pp. 1518-1523
-
-
Joffs, C.1
Gunasinghe, H.R.2
Multani, M.M.3
Dorman, B.H.4
Kratz, J.M.5
Crumbley, A.J.6
Crawford, F.A.7
Spinale, F.G.8
-
16
-
-
0032145662
-
Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes
-
Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, Ueno T, Sugi K, Imaizumi T. Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998;32:368-372.
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 368-372
-
-
Kai, H.1
Ikeda, H.2
Yasukawa, H.3
Kai, M.4
Seki, Y.5
Kuwahara, F.6
Ueno, T.7
Sugi, K.8
Imaizumi, T.9
-
17
-
-
0037631925
-
Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction
-
Kaden JJ, Dempfle CE, Sueselbeck T, Brueckmann M, Poerner TC, Haghi D, Haase KK, Borggrefe M. Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction. Cardiology. 2003;99:140-144.
-
(2003)
Cardiology
, vol.99
, pp. 140-144
-
-
Kaden, J.J.1
Dempfle, C.E.2
Sueselbeck, T.3
Brueckmann, M.4
Poerner, T.C.5
Haghi, D.6
Haase, K.K.7
Borggrefe, M.8
-
18
-
-
0035147051
-
Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome
-
Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J. 2001;141:211-217.
-
(2001)
Am Heart J
, vol.141
, pp. 211-217
-
-
Inokubo, Y.1
Hanada, H.2
Ishizaka, H.3
Fukushi, T.4
Kamada, T.5
Okumura, K.6
-
19
-
-
0000393540
-
Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells
-
Li YY, McTiernan CF, Feldman AM. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. Cardiovasc Res. 1999;42:162-172.
-
(1999)
Cardiovasc Res
, vol.42
, pp. 162-172
-
-
Li, Y.Y.1
McTiernan, C.F.2
Feldman, A.M.3
-
20
-
-
0029806813
-
Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
-
Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem. 1996;271:30375-30380.
-
(1996)
J Biol Chem
, vol.271
, pp. 30375-30380
-
-
Greene, J.1
Wang, M.2
Liu, Y.E.3
Raymond, L.A.4
Rosen, C.5
Shi, Y.E.6
-
21
-
-
13944262039
-
Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy
-
Stroud RE, Deschamps AM, Lowry AS, Hardin AE, Mukherjee R, Lindsey ML, Ramamoorthy S, Zile MR, Spencer WH, Spinale FG. Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. J Card Fail. 2005;11:124-130.
-
(2005)
J Card Fail
, vol.11
, pp. 124-130
-
-
Stroud, R.E.1
Deschamps, A.M.2
Lowry, A.S.3
Hardin, A.E.4
Mukherjee, R.5
Lindsey, M.L.6
Ramamoorthy, S.7
Zile, M.R.8
Spencer, W.H.9
Spinale, F.G.10
-
22
-
-
0024723470
-
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms
-
Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
-
(1989)
J Am Soc Echocardiogr
, vol.2
, pp. 358-367
-
-
Schiller, N.B.1
Shah, P.M.2
Crawford, M.3
DeMaria, A.4
Devereux, R.5
Feigenbaum, H.6
Gutgesell, H.7
Reichek, N.8
Sahn, D.9
Schnittger, I.10
-
23
-
-
0030892804
-
Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases
-
Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr. 1997;7:159-178.
-
(1997)
Crit Rev Eukaryot Gene Expr
, vol.7
, pp. 159-178
-
-
Borden, P.1
Heller, R.A.2
-
24
-
-
1242317083
-
ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway
-
Moon SK, Cha BY, Kim CH. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway. J Cell Physiol. 2004;198:417-427.
-
(2004)
J Cell Physiol
, vol.198
, pp. 417-427
-
-
Moon, S.K.1
Cha, B.Y.2
Kim, C.H.3
-
25
-
-
0034827277
-
Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs
-
Etoh T, Joffs C, Deschamps AM, Davis J, Dowdy K, Hendrick J, Baicu S, Mukherjee R, Manhaini M, Spinale FG. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. Am J Physiol Heart Circ Physiol. 2001;281:H987-H994.
-
(2001)
Am J Physiol Heart Circ Physiol
, vol.281
-
-
Etoh, T.1
Joffs, C.2
Deschamps, A.M.3
Davis, J.4
Dowdy, K.5
Hendrick, J.6
Baicu, S.7
Mukherjee, R.8
Manhaini, M.9
Spinale, F.G.10
-
27
-
-
2942750045
-
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: The Framingham Heart Study
-
Sundstrom J, Evanes JC, Benjamin EJ, Levy D, Larson MG, Sawyer DB, Siwik DA, Colucci WS, Sutherland P, Wilson PWF, Ramachandran VS. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation. 2004;109;2850-2856.
-
(2004)
Circulation
, vol.109
, pp. 2850-2856
-
-
Sundstrom, J.1
Evanes, J.C.2
Benjamin, E.J.3
Levy, D.4
Larson, M.G.5
Sawyer, D.B.6
Siwik, D.A.7
Colucci, W.S.8
Sutherland, P.9
Wilson, P.W.F.10
Ramachandran, V.S.11
-
28
-
-
4444370902
-
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: The Framingham Heart Study
-
Sundstrom J, Evans JC, Benjamin EJ, Levy D, Larson MG, Wawyer DB, Siwik DA, Colucci WS, Wilson PWF, Ramachandran VS. Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham Heart Study. Eur Heart J. 2004;25;1509-1516.
-
(2004)
Eur Heart J
, vol.25
, pp. 1509-1516
-
-
Sundstrom, J.1
Evans, J.C.2
Benjamin, E.J.3
Levy, D.4
Larson, M.G.5
Wawyer, D.B.6
Siwik, D.A.7
Colucci, W.S.8
Wilson, P.W.F.9
Ramachandran, V.S.10
|